Anti-CD19/Anti-CD20 bicistronic CAR-T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-CD19/Anti-CD20 bicistronic CAR-T cells, covering 2026-01-13 to 2026-01-13. Get the full timeline:
Most recent: Clinical Trial Update: Trial of Anti-CD19 and Anti-CD20 Bicistronic Chimeric Antigen Receptor T Cells for Treating B-Cell Malignancies [Phase 1]